We are continuously providing updates all year round, view the updates page here »

Last updated 16 December 2021

Recent releases and updates

Recently completed major releases and updates:

  • Revolutionary Reform path reshaping tool (read more...)

  • Adobe Illustrator 2021 v25.3+ compatibility for rotated artboards (read more...) and 2022

  • Native Apple M1 hardware updates (read more...)

Future plans

Below is our intended* roadmap. Note that regular (typically monthly) additional minor updates are not detailed below.

Adobe Illustrator plugins

  • Reform v2 (Q2 2022)

  • Major, new plugin (we're keeping it secret for the moment!)

Beyond mainstream functional releases, a request-based beta programme opt-in via the Astute Manager is being planned. This will allow for the early deployment of "lab" style tools for testing.

Please refer to our social channels and website for updates.

Training material

Please read our Learning to Learn blog post for insights into the major changes we have planned for our training and learning material. We welcome your feedback!

Astute Manager and user account

  • Astute Manager v3 to bring power consumption improvements, UI/UX enhancements for both macOS and Windows users, plus native Apple M1 hardware compatibility. Expected early 2022.

  • Evolution of the Astute Manager to become a "service hub" for designers, connecting Astute Graphics and external resources.

Do you have a suggestion?

Astute Graphics have been listening to suggestions from customers and users since our first plugin (Phantasm) in 2006. If you have a tool or enhancement that you think would be useful to your vector workflow and other Adobe Illustrator users, please get in contact.

We also actively seek feedback from customers via regular surveys. Our latest one has ensured many improvements are underway. Read about what actions we plan to take »


*We can't provide specific dates or fully predict external factors such as updates by Adobe, Apple and Microsoft. All information provided here is purely an indication and may be subject to change without notice.